These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1532925)

  • 21. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.
    Liao Z; Grimshaw RS; Rosenstreich DL
    J Exp Med; 1984 Jan; 159(1):126-36. PubMed ID: 6607312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.
    Locksley RM; Crowe S; Sadick MD; Heinzel FP; Gardner KD; McGrath MS; Mills J
    J Clin Invest; 1988 Dec; 82(6):2097-105. PubMed ID: 3264291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
    Hernández-Caselles T; Stutman O
    J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of IL 1-induced fibroblast PGE2 production by a urine-derived IL 1 inhibitor.
    Korn JH; Brown KM; Downie E; Liao ZH; Rosenstreich DL
    J Immunol; 1987 May; 138(10):3290-4. PubMed ID: 3494764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.
    Monick M; Glazier J; Hunninghake GW
    Am Rev Respir Dis; 1987 Jan; 135(1):72-7. PubMed ID: 3492161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of IL-2-induced T cell proliferation by a novel factor(s) present in murine spleen dendritic cell-T cell culture supernatants.
    Everson MP; Spalding DM; Koopman WJ
    J Immunol; 1989 Feb; 142(4):1183-94. PubMed ID: 2644351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.
    Rosenstreich DL; Tu JH; Kinkade PR; Maurer-Fogy I; Kahn J; Barton RW; Farina PR
    J Exp Med; 1988 Nov; 168(5):1767-79. PubMed ID: 3263467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Induction of tumor cell killing by human alveolar macrophages and its regulation by IL-4].
    Sone S; Nishioka Y; Nii A; Yanagawa H; Orino E; Mizuno K; Yano S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():207-12. PubMed ID: 1306226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
    Berkman N; John M; Roesems G; Jose PJ; Barnes PJ; Chung KF
    J Immunol; 1995 Nov; 155(9):4412-8. PubMed ID: 7594602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages.
    Raychaudhuri B; Fisher CJ; Farver CF; Malur A; Drazba J; Kavuru MS; Thomassen MJ
    Cytokine; 2000 Sep; 12(9):1348-55. PubMed ID: 10975994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
    Burger D; Chicheportiche R; Giri JG; Dayer JM
    J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative evaluation of gene expression of IL-1 beta and IL-1 receptor antagonist (IL-1ra) from alveolar macrophages in idiopathic pulmonary fibrosis (IPF) and sarcoidosis].
    Shimoji T; Nagai S; Takeuchi M; Saito A; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1409-15. PubMed ID: 8277611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism.
    Lindroos PM; Coin PG; Badgett A; Morgan DL; Bonner JC
    Am J Respir Cell Mol Biol; 1997 Mar; 16(3):283-92. PubMed ID: 9070613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A urine inhibitor of interleukin 1 activity that blocks ligand binding.
    Seckinger P; Lowenthal JW; Williamson K; Dayer JM; MacDonald HR
    J Immunol; 1987 Sep; 139(5):1546-9. PubMed ID: 2957429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of fosfomycin and corticosteroid on the molar ratio of interleukin-1 receptor antagonist/interleukin-1beta in the culture supernatants of mononuclear phagocytes from patients with sarcoidosis.
    Mikuniya T; Nagai S; Takeuchi M; Izumi T
    J Infect Chemother; 2004 Oct; 10(5):293-8. PubMed ID: 16163465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
    Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
    J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes.
    Nicod LP; Galve-De-Rochemonteix B; Dayer JM
    Ann N Y Acad Sci; 1994 May; 725():323-30. PubMed ID: 8031004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.